相似文献
1
Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages.
Infect Immun. 1995 Sep;63(9):3297-301. doi: 10.1128/iai.63.9.3297-3301.1995.
2
Survival of a bacterioferritin deletion mutant of Brucella melitensis 16M in human monocyte-derived macrophages.
Infect Immun. 1997 Oct;65(10):4337-40. doi: 10.1128/iai.65.10.4337-4340.1997.
3
Deletion of purE attenuates Brucella melitensis infection in mice.
Infect Immun. 1996 Jun;64(6):2188-92. doi: 10.1128/iai.64.6.2188-2192.1996.
4
Lymphocyte proliferative responses of goats vaccinated with Brucella melitensis 16M or a delta purE201 strain.
Infect Immun. 1997 Jul;65(7):2987-91. doi: 10.1128/iai.65.7.2987-2991.1997.
5
Attenuation of defined Brucella melitensis wboA mutants.
Vaccine. 2010 Oct 1;28 Suppl 5:F12-6. doi: 10.1016/j.vaccine.2010.03.058. Epub 2010 Apr 1.
6
A multicopper oxidase contributes to the copper tolerance of Brucella melitensis 16M.
FEMS Microbiol Lett. 2015 Jun;362(12):fnv078. doi: 10.1093/femsle/fnv078. Epub 2015 May 7.
7
TceSR two-component regulatory system of Brucella melitensis 16M is involved in invasion, intracellular survival and regulated cytotoxicity for macrophages.
Lett Appl Microbiol. 2015 Jun;60(6):565-71. doi: 10.1111/lam.12408. Epub 2015 Apr 14.
8
Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant.
Vet Microbiol. 1999 Feb 23;65(1):21-36. doi: 10.1016/s0378-1135(98)00281-8.
9
The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
Vet Microbiol. 2011 Aug 5;151(3-4):354-62. doi: 10.1016/j.vetmic.2011.03.031. Epub 2011 Apr 4.
10
Cytotoxicity in macrophages infected with rough Brucella mutants is type IV secretion system dependent.
Infect Immun. 2008 Jan;76(1):30-7. doi: 10.1128/IAI.00379-07. Epub 2007 Oct 15.
引用本文的文献
1
Adhesins of : Their Roles in the Interaction with the Host.
Pathogens. 2020 Nov 12;9(11):942. doi: 10.3390/pathogens9110942.
2
Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.
Vaccine. 2016 Oct 17;34(44):5290-5297. doi: 10.1016/j.vaccine.2016.09.004. Epub 2016 Sep 14.
3
Space: A Final Frontier for Vacuolar Pathogens.
Traffic. 2016 May;17(5):461-74. doi: 10.1111/tra.12382. Epub 2016 Feb 24.
4
Comparison of genomes of Brucella melitensis M28 and the B. melitensis M5-90 derivative vaccine strain highlights the translation elongation factor Tu gene tuf2 as an attenuation-related gene.
Infect Immun. 2013 Aug;81(8):2812-8. doi: 10.1128/IAI.00224-13. Epub 2013 May 28.
5
Integrative genomic analysis identifies isoleucine and CodY as regulators of Listeria monocytogenes virulence.
PLoS Genet. 2012 Sep;8(9):e1002887. doi: 10.1371/journal.pgen.1002887. Epub 2012 Sep 6.
6
Structural and biochemical characterization of N5-carboxyaminoimidazole ribonucleotide synthetase and N5-carboxyaminoimidazole ribonucleotide mutase from Staphylococcus aureus.
Acta Crystallogr D Biol Crystallogr. 2011 Aug;67(Pt 8):707-15. doi: 10.1107/S0907444911023821. Epub 2011 Jul 12.
7
Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.
Med Microbiol Immunol. 2009 Nov;198(4):221-38. doi: 10.1007/s00430-009-0123-8. Epub 2009 Sep 22.
8
Nucleotide biosynthesis is critical for growth of bacteria in human blood.
PLoS Pathog. 2008 Feb 8;4(2):e37. doi: 10.1371/journal.ppat.0040037.
9
Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages.
Infect Immun. 2006 Sep;74(9):5035-46. doi: 10.1128/IAI.01998-05.
10
Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model.
Infect Immun. 2004 Aug;72(8):4911-7. doi: 10.1128/IAI.72.8.4911-4917.2004.
本文引用的文献
1
Interconversion of Purine Mononucleotides in Pasteurella pestis.
Infect Immun. 1970 May;1(5):446-54. doi: 10.1128/iai.1.5.446-454.1970.
2
Immunization with viable Brucella organisms. Results of a safety test in humans.
Bull World Health Organ. 1962;26(3):409-19.
3
Host-parasite relationships in brucellosis. I. Infection of normal guinea pig macrophages in tissue culture.
J Infect Dis. 1958 May-Jun;102(3):258-67. doi: 10.1093/infdis/102.3.258.
4
Intracellular multiplication of Brucella abortus in normal and immune mononuclear phagocytes.
Proc Soc Exp Biol Med. 1957 Jan;94(1):78-83. doi: 10.3181/00379727-94-22860.
5
Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants.
Infect Immun. 1993 Sep;61(9):3756-60. doi: 10.1128/iai.61.9.3756-3760.1993.
6
Salmonella typhimurium loci involved in survival within macrophages.
Infect Immun. 1994 May;62(5):1623-30. doi: 10.1128/iai.62.5.1623-1630.1994.
7
Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
Infect Immun. 1994 Nov;62(11):5168-72. doi: 10.1128/iai.62.11.5168-5172.1994.
8
A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression.
J Bacteriol. 1995 May;177(9):2321-7. doi: 10.1128/jb.177.9.2321-2327.1995.
9
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.
Nature. 1981 May 21;291(5812):238-9. doi: 10.1038/291238a0.
10
Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants.
Infect Immun. 1984 Sep;45(3):649-54. doi: 10.1128/iai.45.3.649-654.1984.
Zotero 插件